New techniques for positron emission tomography in the study of human neurological disorders
Description
The general goals of the physics and kinetic modeling projects are to: (1) improve the quantitative information extractable from PET images, and (2) develop, implement and optimize tracer kinetic models for new PET neurotransmitter/receptor ligands aided by computer simulations. Work towards improving PET quantification has included projects evaluating: (1) iterative reconstruction algorithms using supplemental boundary information, (2) automated registration of dynamic PET emission and transmission data using sinogram edge detection, and (3) automated registration of multiple subjects to a common coordinate system, including the use of non-linear warping methods. Simulation routines have been developed providing more accurate representation of data generated from neurotransmitter/receptor studies. Routines consider data generated from complex compartmental models, high or low specific activity administrations, non-specific binding, pre- or post-injection of cold or competing ligands, temporal resolution of the data, and radiolabeled metabolites. Computer simulations and human PET studies have been performed to optimize kinetic models for four new neurotransmitter/receptor ligands, [11C]TRB (muscarinic), [11C]flumazenil (benzodiazepine), [18F]GBR12909, (dopamine), and [11C]NMPB (muscarinic)
Availability note (English)
MF available from INIS under the Report Number; OSTI as DE92015353; NTIS; INIS; US Govt. Printing Office Dep.
Files
Additional details
Publishing Information
- Imprint Pagination
- 11 p.
- Report number
- DOE/ER/60561--6
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 23079028
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- BLOOD FLOW; CARBON 11; COMPUTERIZED SIMULATION; DOPAMINE; FLUORINE 18; ION EXCHANGE MATERIALS; KINETICS; LABELLED COMPOUNDS; LIGANDS; NERVOUS SYSTEM DISEASES; NEUROREGULATORS; OXYGEN 18; POSITRON COMPUTED TOMOGRAPHY; SIGNAL-TO-NOISE RATIO; SYNTHESIS
- Descriptors DEC
- AMINES; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENT; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBON ISOTOPES; CARDIOTONICS; CARDIOVASCULAR AGENTS; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVEN-EVEN NUCLEI; EVEN-ODD NUCLEI; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; HYDROXY COMPOUNDS; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; MATERIALS; MINUTES LIVING RADIOISOTOPES; NANOSEC LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; OXYGEN ISOTOPES; PHENOLS; POLYPHENOLS; RADIOISOTOPES; SIMULATION; STABLE ISOTOPES; SYMPATHOMIMETICS; TOMOGRAPHY
Optional Information
- Contract/Grant/Project number
- Contract FG02-87ER60561
- Funding organization
- USDOE, Washington, DC (United States).